Adam O'Dell's $5 Stock Summit is all about a green line, yes a green line.
The line is part of an AI stock rating system that has identified five stocks with the potential to appreciate by 500% this year.
On a chart, the green line represents the $5 mark, and understanding its power can lead to explosive profits.
Adam explains that when the stock price of a good company trades above $5 a share, it gets everyone’s attention.
I am well aware of micro and small-caps flying under the radar due to their exclusion from indexes and by extension institutional ownership. Even more so if they happen to have an “off-market” OTC listing.
But it seems $5 is also a demarcation line of sorts, as many institutions like mutual and pension funds are restricted from owning stocks with prices below this level.
There are myriad reasons for this and they start with the movie Boiler Room!?
In the movie, a fictional penny stock brokerage – J.T. Marlin, hard sells pump-and-dump stocks at high commissions to unsuspecting seniors over the phone.
This isn't far removed from what the very real Long Island brokerage J. T. Moran & Company did in the early 90s. As a result, the Securities and Exchange Commission cracked down and now brokers can't process trades in stocks worth less than $5 without following a laundry list of rules and processes.
So essentially, a stock below this price point becomes invisible to Wall Street. This presents a massive opportunity for individual investors.
A Strategy for Turbulent Markets
Undervalued stocks are a welcome sight anytime, but especially during turbulent markets.
For example, following the dot-com crash in 2000, the top 10 performing stocks for the year had an average share price of only $3.96. Stocks like Apple, NVIDIA, and Steel Dynamics all traded well below $5 and have gone on to see an average gain of 16,500% since that time.
We’re now seeing this same scenario play out again, with stocks like Enliven Therapeutics (Nasdaq: ELVN), which traded below $5 for most of 2022, only to spike by 460% over 10 months.
As a result of the see-saw market over the last few years, Adam says there are now nearly 2,000 stocks trading below $5 a share and he's cut through the chaff to find five that are too good to pass up.
Adam has put everything we need to know in a brand-new “fast-action” report called, The Exponential Profits Portfolio: 5 Stocks Set to Surge 500% This Year.
As good as this opportunity is, Adam wants to give us regular opportunities like this one, not just now, but twelve times per year with his new stock-picking research service, 10X Stocks.
The cost of this “elite, VIP service” is $1,495 for the first year and it comes with at least one new stock pick per month, instant trade alerts, a weekly market update…even if it has been a slow week, and a U.S. based customer support team.
The $5 Stocks Worth Buying
According to Adam, a whopping 1 in every 5 stocks are currently trading below $5.
This is a double-edged sword.
On one hand, some truly amazing profit opportunities are just sitting there waiting for us. Between 2002 and 2009 there were nearly 700 stocks that were below $5 that went on to see more than a 10x gain.
On the other hand, there are a whole lot of bad stocks out there, that aren't worth buying even with someone else's money. How do we tell the diamonds in the rough from the duds?
Never fear, because Adam is here with a patent-pending stock-rating system.
The 6 Factors That Drive Market-Beating Returns
Adam confides that his system is an AI-based software, that ranks stocks on six price-based and fundamental factors.
This is the system in action:
He claims bullish stocks rated 80 and above on his system, have been proven to beat the market, 3 to 1 over the last 20 years!
In his own words, “it's the perfect way to quickly separate the wheat from the chaff, and narrow down the best opportunities to go deeper with my strategy.”
As a further safeguard, stop-losses of 30-50% are also put in place for every stock the system recommends.
Normally, one, maybe two high-quality stocks per month are uncovered with this strategy, but right now, Adam is sitting on five recommendations. Let's find out what they are.
Revealing Adam O’Dell’s $5 Stock Summit Stocks
All of the indicators in Adam's system are screaming that these stocks are about to surge higher.
This is followed by only a single clue about all five stocks.
The CEOs of all five stocks under $5 are founders with skin in the game. Not much to go on, but it's a start.
I ran a stock screen for this criteria and it returned the following names:
- Allogene Therapeutics Inc. (Nasdaq: ALLO)
- LivePerson Inc. (Nasdaq: LPSN)
- Medical Properties Trust Inc. (NYSE: MPW)
That's it, at least for Nasdaq and NYSE-listed businesses.
This means the final two must be either OTC or foreign-listed stocks, which my screener tool wasn't able to capture. We can implant wireless chips in people's brains, but we can't have a global stock screener. Where's Elon Musk when you need him?
Make 1,500% or More This Year?
Historically speaking, founder-led businesses tend to outperform the rest.
Combine this with under-bought stocks selling for less than $5 and we get sure-fire winners, right?
Not so fast skippy.
Two of Adam's three picks that we revealed are currently in the red and only one is moderately interesting – Medical Properties Trust.
MPW owns a portfolio of 441 hospitals and care facilities across 10 countries that are worth a combined $19 billion. The REIT does have around $10.4 billion in mortgage debt outstanding on these properties, leaving some $8.6 billion in net tangible assets.
This figure is a long way removed from its present market cap of slightly under $2 billion.
Yes, you read that right, $2 billion! I had to double-check these figures myself and I can confirm that they are indeed accurate.
What's more, the majority of MPW's principal debt payments aren't due until after 2027. So the stock is valued absurdly low for a business that owns billions of dollars worth of tangible property and isn't facing any immediate solvency crisis like the Evergrande Group.
The REIT did slash its dividend last year, which the market is overreacting to, and it has stated that “it does not expect any material acquisitions of real estate in the foreseeable future”, putting a damper on growth expectations.
But Wall Street's loss is our gain, as MPW at its currently prevailing price presents us with the three sweetest words in investing…margin of safety.
Quick Recap & Conclusion
- Adam O'Dell's $5 Stock Summit is all about five stocks with the potential to surge 500% this year.
- All five were identified by Adam's AI-based Stock Power Ratings system, which he claims has beat the market 3 to 1 over the last 20 years.
- The names of all five stocks are revealed in a special report called, The Exponential Profits Portfolio: 5 Stocks Set to Surge 500% This Year. It is ours with a subscription to the 10X Stocks research service, which costs $1,495 for the first year.
- Adam only drops a single clue about his five top-rated stocks, that they are all founder-led and we were able to reveal three of them right here for free. They are Allogene Therapeutics Inc. (Nasdaq: ALLO), LivePerson Inc. (Nasdaq: LPSN), and Medical Properties Trust Inc. (NYSE: MPW).
- Two of Adam's three picks are in the red and the other – MPW is selling for less than a quarter of its net asset value, presenting the only real opportunity of the bunch.
Which one or two of Adam's six stock rating factors do you weigh the most when investing? Let us know in the comments below.